Found: 38
Select item for more details and to access through your institution.
Skeletal muscle‐specific overexpression of heat shock protein 72 improves skeletal muscle insulin‐stimulated glucose uptake but does not alter whole body metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1928, doi. 10.1111/dom.13319
- By:
- Publication type:
- Article
Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2029, doi. 10.1111/dom.13320
- By:
- Publication type:
- Article
Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1921, doi. 10.1111/dom.13318
- By:
- Publication type:
- Article
Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1937, doi. 10.1111/dom.13321
- By:
- Publication type:
- Article
Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1812, doi. 10.1111/dom.13317
- By:
- Publication type:
- Article
Cover Image, Volume 20, Issue 8.
- Published in:
- 2018
- By:
- Publication type:
- Cover Art
This is in reply to the Letter by Kahathuduwa et al. titled “Unaccounted for regression to the mean renders conclusion of article titled ‘Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin’ unsubstantiated”
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Mortality risk remains higher in individuals with type 1 diabetes: A population‐based cohort study (the Ayrshire diabetes follow‐up cohort [ADOC]).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1965, doi. 10.1111/dom.13334
- By:
- Publication type:
- Article
HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1957, doi. 10.1111/dom.13332
- By:
- Publication type:
- Article
Bone: Another potential target to treat, prevent and predict diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1817, doi. 10.1111/dom.13330
- By:
- Publication type:
- Article
Long‐term treatment with metformin in type 2 diabetes and vitamin D levels: A post‐hoc analysis of a randomized placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1951, doi. 10.1111/dom.13327
- By:
- Publication type:
- Article
Exenatide effects on gastric emptying rate and the glucose rate of appearance in plasma: A quantitative assessment using an integrative systems pharmacology model.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2034, doi. 10.1111/dom.13326
- By:
- Publication type:
- Article
The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1809, doi. 10.1111/dom.13325
- By:
- Publication type:
- Article
Unaccounted for regression to the mean renders conclusion of article titled “Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin” unsubstantiated.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Efficacy and safety of MYL‐1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks: Results of the INSTRIDE 1 phase III study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1944, doi. 10.1111/dom.13322
- By:
- Publication type:
- Article
Effects on the glucagon response to hypoglycaemia during DPP‐4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo‐controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1911, doi. 10.1111/dom.13316
- By:
- Publication type:
- Article
Baseline characteristics and enrichment results from the SONAR trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1829, doi. 10.1111/dom.13315
- By:
- Publication type:
- Article
Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2023, doi. 10.1111/dom.13313
- By:
- Publication type:
- Article
Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1903, doi. 10.1111/dom.13311
- By:
- Publication type:
- Article
Determining the optimal dose of atrasentan by evaluating the exposure‐response relationships of albuminuria and bodyweight.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2019, doi. 10.1111/dom.13312
- By:
- Publication type:
- Article
Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double‐blind, placebo‐controlled clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1878, doi. 10.1111/dom.13305
- By:
- Publication type:
- Article
Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1894, doi. 10.1111/dom.13310
- By:
- Publication type:
- Article
In response to: Heise T, Nørskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes. Diabetes Obes Metab. 2017;19:1032–1039
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Mobile phone applications and self‐management of diabetes: A systematic review with meta‐analysis, meta‐regression of 21 randomized trials and GRADE.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2009, doi. 10.1111/dom.13307
- By:
- Publication type:
- Article
Haemoglobin A1c variability is a strong, independent predictor of all‐cause mortality in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1885, doi. 10.1111/dom.13306
- By:
- Publication type:
- Article
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2014, doi. 10.1111/dom.13309
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- 2018
- Publication type:
- Cover Art
Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2004, doi. 10.1111/dom.13304
- By:
- Publication type:
- Article
Burden of cardio‐renal‐metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2000, doi. 10.1111/dom.13303
- By:
- Publication type:
- Article
Metformin's impact on statin‐associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1994, doi. 10.1111/dom.13302
- By:
- Publication type:
- Article
Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1988, doi. 10.1111/dom.13301
- By:
- Publication type:
- Article
Comparative efficacy and safety of the duodenal‐jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1868, doi. 10.1111/dom.13300
- By:
- Publication type:
- Article
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1983, doi. 10.1111/dom.13299
- By:
- Publication type:
- Article
Distinct gene expression pathways in islets from individuals with short‐ and long‐duration type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1859, doi. 10.1111/dom.13298
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1852, doi. 10.1111/dom.13297
- By:
- Publication type:
- Article
SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1977, doi. 10.1111/dom.13295
- By:
- Publication type:
- Article
SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1972, doi. 10.1111/dom.13294
- By:
- Publication type:
- Article
Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1836, doi. 10.1111/dom.13212
- By:
- Publication type:
- Article